Here, we identified 4-1BB and Tim-3, immune checkpoints that are implicated in modulating autoimmunity and considered targets for immunotherapy [35, 37], as upregulated in lesion core astrocytes (Fig. 5a, f). This evidence concerns the gene HAVCR2 and Autoimmunity.